Cornerstone Planning Group LLC Autolus Therapeutics PLC Transaction History
Cornerstone Planning Group LLC
- $378 Billion
- Q3 2024
A detailed history of Cornerstone Planning Group LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 100 shares of AUTL stock, worth $334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$334
Previous $425,000
2.12%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
115Shares Held
166MCall Options Held
34.2KPut Options Held
19.5K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$71.3 Million86.45% of portfolio
-
Blackstone Inc New York, NY20.5MShares$68.4 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA17.9MShares$59.8 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$51 Million1.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$41.2 Million0.59% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $304M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...